8-Sep-2026
Doximity falls as Freedom Capital downgrades on revised EBITDA outlook
Seeking Alpha News (Tue, 8-Sep 2:30 PM ET)
TipRanks (Tue, 8-Sep 8:00 AM ET)
Overworked Doctors Bet on AI to Boost Their Pay
Business Wire (Tue, 25-Aug 9:05 AM ET)
Doximity Projects Robust Revenue Growth Despite Margin Pressures and Record Engagement
Market Chameleon (Fri, 7-Aug 6:28 AM ET)
Doximity Announces Fiscal 2027 First Quarter Financial Results
Business Wire (Thu, 6-Aug 4:01 PM ET)
Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026
Business Wire (Thu, 16-Jul 4:01 PM ET)
Business Wire (Wed, 15-Jul 2:26 PM ET)
Did Doximity Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Fri, 3-Jul 12:32 PM ET)
Globe Newswire (Tue, 23-Jun 5:43 PM ET)
Globe Newswire (Tue, 9-Jun 1:47 PM ET)
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
Doximity Class A trades on the NYSE stock market under the symbol DOCS.
As of September 8, 2026, DOCS stock price declined to $24.42 with 2,814,034 million shares trading.
DOCS has a beta of 1.98, meaning it tends to be more sensitive to market movements. DOCS has a correlation of 0.14 to the broad based SPY ETF.
DOCS has a market cap of $4.39 billion. This is considered a Mid Cap stock.
Last quarter Doximity Class A reported $157 million in Revenue and $.29 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.02.
In the last 3 years, DOCS traded as high as $85.21 and as low as $17.15.
The top ETF exchange traded funds that DOCS belongs to (by Net Assets): IJH, VTI, VB, VBK, XMHQ.
DOCS has underperformed the market in the last year with a price return of -64.4% while the SPY ETF gained +19.2%. However, in the short term, DOCS had mixed performance relative to the market. It has outperformed in the last 3 months, returning +18.0% vs +1.4% return in SPY. But in the last 2 weeks, DOCS shares have been beat by the market, returning -3.6% compared to an SPY return of 0.0%.
DOCS support price is $25.41 and resistance is $27.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOCS shares will trade within this expected range on the day.